Principles of Psychopharmacology for Mental Health Professionals

個数:

Principles of Psychopharmacology for Mental Health Professionals

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 389 p.
  • 言語 ENG
  • 商品コード 9780471254010
  • DDC分類 615.78

Full Description

Principles of Psychopharmacology for Mental Health Professionals addresses the current "split" model of mental health care, in which physicians provide pharmaco-therapy while non-prescribing practitioners oversee other services such as psychotherapy. Bringing these two areas together, this book familiarizes mental health professionals with the medications used to treat psychiatric disorders.

Prepared by world-renowned psychopharmacologists and psychiatrists, this useful resource helps non-prescribing practitioners understand when and why a given medication is appropriate to use, when it is not indicated, and what potential side effects may occur. Also discussed are the appropriate times in therapy when a referral for a medication evaluation is indicated as well as how to broach this issue with the patient. Recognizing that there are almost always a number of medications from which to choose, the authors combine research outcomes with their extensive clinical experience to highlight the important considerations in selecting one medication over another. As an educational tool, the text encourages and supports clinicians who wish to increase patients' understanding of treatment.

After an introduction and overview, chapters cover:
* Basics of psychopharmacology
* Attention-deficit hyperactivity disorder
* Mood disorders
* Sleep disorders
* Schizophrenia
* Cognitive disorders
* Anxiety disorders
* Personality disorders
* Substance use disorders
* Traumatic brain injury
* Eating disorders
* Side effects


Every chapter includes diagnostic considerations, history of medication treatments, and emerging trends for each disease.

Principles of Psychopharmacology for Mental Health Professionals lays out what psychotherapists and other mental health practitioners need to know about psychotropic medications, giving them and their patients an invaluable guide to the full array of treatments available.

Contents

Preface. Faculty Disclosure.

1 INTRODUCTION AND OVERVIEW.

Additional Reading.

2 BASICS OF PSYCHOPHARMACOLOGY.

2.1 Introduction.

2.3 Pathophysiology: Study of What Goes Wrong.

2.4 Pharmacology.

2.5 Putting It All Together.

Additional Reading.

3 MOOD DISORDERS.

3.1 Introduction.

3.2 Major Depressive Disorder.

3.3 Dysthymic Disorder.

3.4 Bipolar Disorders.

Additional Reading.

4 SCHIZOPHRENIA.

4.1 Brief Description and Diagnostic Criteria.

4.2 Prevalence and Risk Factors.

4.3 Presentation and Clinical Course.

4.4 Initial Evaluation and Differential Diagnosis.

4.5 History of Treatment.

4.6 Current Approach to Treatment.

4.7 Treatment Resistant Schizophrenia.

Additional Reading.

5 ANXIETY DISORDERS.

5.1 Introduction.

5.2 Panic Disorder.

5.3 Generalized Anxiety Disorder.

5.4 Obsessive-Compulsive Disorder.

5.5 Social Anxiety Disorder (Social Phobia).

5.6 Post-Traumatic Stress Disorder.

Additional Reading.

6 SUBSTANCE USE DISORDERS.

6.1 Introduction.

6.2 Brief Description and Diagnostic Criteria.

6.3 Prevalence and Risk Factors.

6.4 Presentation and Clinical Course.

6.5 Initial Evaluation and Differential Diagnosis.

6.6 History of Treatment.

6.7 Current Approaches to Treatment.

6.8 Alcohol Use Disorders.

6.9 Cocaine Use Disorders.

6.10 Nicotine Dependence.

6.11 Opiate Use Disorders.

Additional Reading.

7 EATING DISORDERS.

7.1 Introduction.

7.2 Anorexia Nervosa.

7.3 Bulimia Nervosa.

7.4 Binge-Eating Disorder.

Additional Reading.

8 ATTENTION DEFICIT-HYPERACTIVITY DISORDER.

8.1 Brief Description and Diagnostic Criteria.

8.2 Prevalence and Risk Factors.

8.3 Presentation and Clinical Course.

8.4 Initial Evaluation and Differential Diagnosis.

8.5 History of Pharmacological Treatment.

8.6 Current Approach to Treatment.

Additional Reading.

9 SLEEP DISORDERS.

9.1 Introduction.

9.2 Insomnia.

9.3 Narcolepsy.

Additional Reading.

10 ALZHEIMER'S DISEASE AND OTHER DEMENTIAS.

10.1 Brief Description and Diagnostic Criteria.

10.2 Prevalence and Risk Factors.

10.3 Presentation and Clinical Course.

10.4 Initial Evaluation and Differential Diagnosis.

10.5 History of Pharmacological Treatment.

10.6 Current Approach to Treatment.

Additional Reading.

11 PERSONALITY DISORDERS.

11.1 Introduction.

11.2 Cluster A: Odd and Eccentric Personality Disorders.

11.3 Cluster B: Dramatic and Emotional Personality Disorders.

11.4 Cluster C: Anxious and Fearful Personality Disorders.

Additional Reading.

12 TRAUMATIC BRAIN INJURY.

12.1 Introduction.

12.2 Approaches to Treatment.

Additional Reading.

13 MANAGING SIDE EFFECTS.

13.1 Introduction.

13.2 Norepinephrine-Related Side Effects.

13.3 Dopamine-Related Side Effects.

13.4 Serotonin-Related Side Effects.

13.5 GABA-Related Side Effects.

13.6 Acetylcholine-Related Side Effects.

13.7 Histamine-Related Side Effects.

Index.

最近チェックした商品